Published in Vaccine Weekly, April 17th, 2002
Memphis, one of the major shipping hubs in the world, was chosen to facilitate the efficient transport and distribution of patient vaccines to treatment centers across the United States.
The facility sets the stage for Cell Genesys' product development strategy for GVAX lung cancer vaccines which includes establishing a centrally located GMP (good manufacturing practices) facility to receive and process...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly